|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Real estate: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Building and improvements | ||||||||||||||||||||
| In-place lease intangible assets | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| Total real estate | ||||||||||||||||||||
| Less: accumulated depreciation and amortization | ||||||||||||||||||||
| Total real estate, net | ||||||||||||||||||||
| Investments in unconsolidated entity | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Assets held for sale, net | ||||||||||||||||||||
| Assets related to discontinued operations, net | ||||||||||||||||||||
| Above-market lease intangible assets, net | ||||||||||||||||||||
| Deferred rent receivable | ||||||||||||||||||||
| Deferred leasing costs, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Right-of-use lease assets | ||||||||||||||||||||
| Interest rate swap asset | ||||||||||||||||||||
| Interest rate swap asset, at fair value | ||||||||||||||||||||
| Interest Rate Swap | ||||||||||||||||||||
| Total interest rate swap asset, at fair value | ||||||||||||||||||||
| Real estate assets and other assets held for sale, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Restricted reserves | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Interest rate swap liability, at fair value | ||||||||||||||||||||
| Interest Rate Swap | ||||||||||||||||||||
| Total interest rate swap liability, at fair value | ||||||||||||||||||||
| Redemptions payable | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related parties | ||||||||||||||||||||
| Intangible liabilities, net | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Below-market lease intangible liabilities, net | ||||||||||||||||||||
| Right-of-use lease liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued expenses and other liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Liabilities related to discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Perpetual convertible preferred shares | ||||||||||||||||||||
| Total perpetual convertible preferred shares | ||||||||||||||||||||
| Noncontrolling interests subject to redemption; zero and 61,788 units as of December 31, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common shares, $0.001 par value; 800,000,000 shares authorized; 37,187,359 and 37,176,167 shares outstanding in the aggregate as of March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Cumulative distributions | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Units eligible towards redemption (in shares) | ||||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||||
Loading...